AKT1 and pulmonary fibrosis: It has been reported that the PI3K/AKT signaling pathway is a key signaling node in idiopathic pulmonary fibrosis (IPF), and PI3K/AKT inhibitors can inhibit the progression of IPF, which has been verified in clinical trials [71].